Robert Lanza
- Molecular Biology top 0.5%
- Pluripotent Stem Cells Research 51
- CRISPR and Genetic Engineering 33
- Retinal Development and Disorders 15
- Renal and related cancers 13
- Ophthalmology top 0.5%
- Genetics top 0.5%
- Diabetes and associated disorders 15
- Mesenchymal stem cell research 12
- Developmental Neuroscience top 1%
-
- Pancreatic function and diabetes 38
-
- Diabetes Management and Research 13
- Co-authors
- Irina KlimanskayaMichael D. WestWilliam L. ChickErin A. KimbrelAnthony AtalaYoung Sun ChungShi‐Jiang LuJosé B. Cibelli
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Robert Lanza
140 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Molecular Biology 9.6k
- Ophthalmology 1.1k
- Genetics 1.1k
- Developmental Neuroscience 379
- Cellular and Molecular Neuroscience 1.5k
Countries citing papers authored by Robert Lanza
This map shows the geographic impact of Robert Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lanza more than expected).
Fields of papers citing papers by Robert Lanza
This network shows the impact of papers produced by Robert Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lanza. The network helps show where Robert Lanza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Lanza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data | 2018 | 2 |
| 2 | 2014 | 140 | |
| 3 | 2010 | 5 | |
| 4 | 2009 | 64 | |
| 5 | Essential stem cell methods | 2009 | 6 |
| 6 | 2009 | 42 | |
| 7 | Una nueva teoría del universo. Con la vida en la ecuación, el biocentrismo crece con la física cuántica | 2007 | 0 |
| 8 | 2007 | 22 | |
| 9 | 2006 | 297 | |
| 10 | 2005 | 6 | |
| 11 | 2005 | 1 | |
| 12 | 2004 | 311 | |
| 13 | Methods of tissue engineering | 2002 | 342 |
| 14 | 2001 | 58 | |
| 15 | 2000 | 263 | |
| 16 | 1999 | 164 | |
| 17 | 1990 | 19 | |
| 18 | An in vitro method of assessing the immunoprotective properties of microcapsule membranes using pancreatic and tumor cell targets. | 1990 | 12 |
| 19 | 1984 | 254 | |
| 20 | Heart transplantation : the present status of orthotopic and heterotopic heart transplantation | 1984 | 4 |
About Robert Lanza
Robert Lanza is a scholar working on Transplantation, Surgery, Genetics, Genetics and Molecular Biology, having authored 145 papers that have together received 14.0k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (51 papers), Pancreatic function and diabetes (38 papers), CRISPR and Genetic Engineering (33 papers), Diabetes and associated disorders (15 papers), Retinal Development and Disorders (15 papers), Diabetes Management and Research (13 papers), Renal and related cancers (13 papers) and Mesenchymal stem cell research (12 papers). The work is most often cited by research in Molecular Biology (9.6k citations), Ophthalmology (1.1k citations), Genetics (1.1k citations), Developmental Neuroscience (379 citations) and Cellular and Molecular Neuroscience (1.5k citations). Robert Lanza has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Irina Klimanskaya, Michael D. West, William L. Chick, Erin A. Kimbrel, Anthony Atala, Young Sun Chung, Shi‐Jiang Lu, José B. Cibelli, Dohoon Kim and Steven D. Schwartz. Their work appears in journals such as Regenerative Medicine, Transplantation, Science, Nature and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.